1. Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer
   Makiko Ogawa et al, 2024, PLOS ONE CrossRef
2. Prognostic Value and Immune Signatures of Anoikis-related Genes in Breast Cancer
   Qing Wu et al, 2024, Journal of Immunotherapy CrossRef
3. CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA–protein ternary complex
   Qiang Ma et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
4. A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance
   Chandrima Das et al, 2024, Oncogene CrossRef
5. MicroRNAs and Their Targets Could Have a Crucial Role in Breast Cancer Drug Resistance: A Bioinformatics Research
   Murat Kaya, 2024, Genel Tıp Dergisi CrossRef
6. Hypoxia-mimetic by CoCl2 increases SLC7A5 expression in breast cancer cells in vitro
   Leonora Canhasi et al, 2023, BMC Research Notes CrossRef
7. Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma
   Vittorio Branchi et al, 2024, Human Pathology CrossRef
8. Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer
   Renhong Huang et al, 2023, Frontiers in Immunology CrossRef
9. Trajectory mapping of renal clear cell carcinoma transcriptomes identifies stage-independent predictors of favorable prognosis
   Jie Sheng et al, 2024, Oncologie CrossRef
10. Transcriptomic analysis and validation study of key genes and the HIF‑1α/HO‑1 pathway associated with ferroptosis in neutrophilic asthma
    Lu Lin et al, 2024, Experimental and Therapeutic Medicine CrossRef